Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Ertel

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Cancer Informatics|March 18, 2010
Bimodal gene expression and biomarker discoveryAdam Ertel
BMC Genomics|January 8, 2008
Switch-like genes populate cell communication pathways and are enriched for extracellular proteinsAdam Ertel, Aydin Tozeren
BMC Genomics|December 25, 2008
Human and mouse switch-like genes share common transcriptional regulatory mechanisms for bimodalityAdam Ertel, Aydin Tozeren
Epigenetics & Chromatin|June 10, 2016
Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injuryMelissa T Manners, Adam Ertel, Yuzhen Tian, et al.
BMC Bioinformatics|October 30, 2007
Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasetsMichael Gormley, William Dampier, Adam Ertel, et al.
BMC Bioinformatics|February 15, 2020
iSeqQC: a tool for expression-based quality control in RNA sequencingGaurav Kumar, Adam Ertel, George Feldman, et al.
Plos One|January 6, 2010
Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell modelA Kathleen McClendon, Jeffry L Dean, Adam Ertel, et al.
Molecular Cancer|November 4, 2006
Pathway-specific differences between tumor cell lines and normal and tumor tissue cellsAdam Ertel, Arun Verghese, Stephen W Byers, et al.
Journal of Cellular Physiology|December 16, 2018
Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancerSeema Bhatlekar, Adam Ertel, Gregory E Gonye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancerAgnieszka K Witkiewicz, Adam Ertel, Jeanne McFalls, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Cancer Informatics|March 18, 2010
Bimodal gene expression and biomarker discoveryAdam Ertel
BMC Genomics|January 8, 2008
Switch-like genes populate cell communication pathways and are enriched for extracellular proteinsAdam Ertel, Aydin Tozeren
BMC Genomics|December 25, 2008
Human and mouse switch-like genes share common transcriptional regulatory mechanisms for bimodalityAdam Ertel, Aydin Tozeren
Epigenetics & Chromatin|June 10, 2016
Genome-wide redistribution of MeCP2 in dorsal root ganglia after peripheral nerve injuryMelissa T Manners, Adam Ertel, Yuzhen Tian, et al.
BMC Bioinformatics|October 30, 2007
Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasetsMichael Gormley, William Dampier, Adam Ertel, et al.
BMC Bioinformatics|February 15, 2020
iSeqQC: a tool for expression-based quality control in RNA sequencingGaurav Kumar, Adam Ertel, George Feldman, et al.
Plos One|January 6, 2010
Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell modelA Kathleen McClendon, Jeffry L Dean, Adam Ertel, et al.
Molecular Cancer|November 4, 2006
Pathway-specific differences between tumor cell lines and normal and tumor tissue cellsAdam Ertel, Arun Verghese, Stephen W Byers, et al.
Journal of Cellular Physiology|December 16, 2018
Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancerSeema Bhatlekar, Adam Ertel, Gregory E Gonye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancerAgnieszka K Witkiewicz, Adam Ertel, Jeanne McFalls, et al.
Pageof 9